TM Supplemental Information February 5, 2024 Non-GAAP Financial Measures Promising start to FY24 – seeing benefits of core protein portfolio — Q1 Fiscal 2024 Certain information in this presentation constitutes forward-looking statements as contemplated by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, current views and estimates of our outlook for fiscal 2023, other future economic circumstances, industry conditions in domestic and int ...